ObvioHealth extends its strategic alliance with Dedalus Group. The two companies first partnered in 2021 to allow ObvioHealth to evaluate anonymized analytics of Dedalus's healthcare records. This new agreement grants ObvioHealth use of Dedalus's data mining and analytics tools for their own research as well as that of its partners and sponsors. This technology will enable access to analytics of ObvioHealth's own multi-source healthcare data.
Read more about the partnership here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.